Singapore, 31 August 2026 – Singapore is strengthening the commercial pathway from public research to investible businesses under its S$37 billion, or US$29 billion, Research, Innovation and Enterprise 2030 plan. The five-year programme combines strategic research funding with new mechanisms intended to move early-stage technologies beyond laboratories, attract private capital and build companies capable of competing in global deep-technology markets.
A new Research Translation Grant will provide up to S$2 million per project, rising to S$3 million where investors become involved at an early stage. The structure is designed to incorporate commercial considerations before technologies reach a late development phase. Universities and the Agency for Science, Technology and Research will be able to work more directly on products and intellectual property that private-sector partners can evaluate, finance and scale.
Unlock the Full Article
This article is exclusive to The Ledger Asia Subsribers / PAID members.
Already have an account? Log in here